822 related articles for article (PubMed ID: 15531889)
21. Design, synthesis, and cholesterol-lowering efficacy for prodrugs of berberrubine.
Li YH; Li Y; Yang P; Kong WJ; You XF; Ren G; Deng HB; Wang YM; Wang YX; Jiang JD; Song DQ
Bioorg Med Chem; 2010 Sep; 18(17):6422-8. PubMed ID: 20673726
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and structure-activity relationship of berberine analogues in LDLR up-regulation and AMPK activation.
Wang YX; Kong WJ; Li YH; Tang S; Li Z; Li YB; Shan YQ; Bi CW; Jiang JD; Song DQ
Bioorg Med Chem; 2012 Nov; 20(22):6552-8. PubMed ID: 23058107
[TBL] [Abstract][Full Text] [Related]
23. The medicinal plant goldenseal is a natural LDL-lowering agent with multiple bioactive components and new action mechanisms.
Abidi P; Chen W; Kraemer FB; Li H; Liu J
J Lipid Res; 2006 Oct; 47(10):2134-47. PubMed ID: 16885565
[TBL] [Abstract][Full Text] [Related]
24. Synergetic cholesterol-lowering effects of main alkaloids from Rhizoma Coptidis in HepG2 cells and hypercholesterolemia hamsters.
Kou S; Han B; Wang Y; Huang T; He K; Han Y; Zhou X; Ye X; Li X
Life Sci; 2016 Apr; 151():50-60. PubMed ID: 26876917
[TBL] [Abstract][Full Text] [Related]
25. The effect of atorvastatin treatment on lipid profile and adhesion molecule levels in hypercholesterolemic patients: relation to low-density lipoprotein receptor gene polymorphism.
Bolewski A; Lipiecki J; Plewa R; Burchardt P; Siminiak T
Cardiology; 2008; 111(2):140-6. PubMed ID: 18376126
[TBL] [Abstract][Full Text] [Related]
26. The safety and anti-hypercholesterolemic effect of coptisine in Syrian golden hamsters.
He K; Ye X; Wu H; Wang Y; Zou Z; Ning N; Hu Y; Chen B; Fang X; Li X
Lipids; 2015 Feb; 50(2):185-94. PubMed ID: 25547428
[TBL] [Abstract][Full Text] [Related]
27. Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response.
Arazi SS; Genvigir FD; Willrich MA; Hirata MH; Dorea EL; Bernik M; Hirata RD
Clin Chim Acta; 2008 Jul; 393(2):119-24. PubMed ID: 18435918
[TBL] [Abstract][Full Text] [Related]
28. Hepatocyte nuclear factor 1alpha plays a critical role in PCSK9 gene transcription and regulation by the natural hypocholesterolemic compound berberine.
Li H; Dong B; Park SW; Lee HS; Chen W; Liu J
J Biol Chem; 2009 Oct; 284(42):28885-95. PubMed ID: 19687008
[TBL] [Abstract][Full Text] [Related]
29. Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity.
Kim WS; Lee YS; Cha SH; Jeong HW; Choe SS; Lee MR; Oh GT; Park HS; Lee KU; Lane MD; Kim JB
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E812-9. PubMed ID: 19176354
[TBL] [Abstract][Full Text] [Related]
30. Berberine decreases cholesterol levels in rats through multiple mechanisms, including inhibition of cholesterol absorption.
Wang Y; Yi X; Ghanam K; Zhang S; Zhao T; Zhu X
Metabolism; 2014 Sep; 63(9):1167-77. PubMed ID: 25002181
[TBL] [Abstract][Full Text] [Related]
31. The berberine-enriched gut commensal Blautia producta ameliorates high-fat diet (HFD)-induced hyperlipidemia and stimulates liver LDLR expression.
Yang YN; Wang QC; Xu W; Yu J; Zhang H; Wu C
Biomed Pharmacother; 2022 Nov; 155():113749. PubMed ID: 36174380
[TBL] [Abstract][Full Text] [Related]
32. The natural compound berberine positively affects macrophage functions involved in atherogenesis.
Zimetti F; Adorni MP; Ronda N; Gatti R; Bernini F; Favari E
Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):195-201. PubMed ID: 25240689
[TBL] [Abstract][Full Text] [Related]
33. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
[TBL] [Abstract][Full Text] [Related]
34. Biochemical pathways in the antiatherosclerotic effect of berberine.
Guo Y; Wang QZ; Li FM; Jiang X; Zuo YF; Wang L
Chin Med J (Engl); 2008 Jul; 121(13):1197-203. PubMed ID: 18710638
[TBL] [Abstract][Full Text] [Related]
35. Coordinated alteration of hepatic gene expression in fatty acid and triglyceride synthesis in LCAT-null mice is associated with altered PUFA metabolism.
Song H; Zhu L; Picardo CM; Maguire G; Leung V; Connelly PW; Ng DS
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E17-E25. PubMed ID: 16105858
[TBL] [Abstract][Full Text] [Related]
36. A new feature on the cholesterol-lowering landscape.
Rader DJ
Nat Med; 2001 Dec; 7(12):1282-4. PubMed ID: 11726962
[No Abstract] [Full Text] [Related]
37. Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine.
Brusq JM; Ancellin N; Grondin P; Guillard R; Martin S; Saintillan Y; Issandou M
J Lipid Res; 2006 Jun; 47(6):1281-8. PubMed ID: 16508037
[TBL] [Abstract][Full Text] [Related]
38. Hepatic tissue sterol regulatory element binding protein 2 and low-density lipoprotein receptor in nephrotic syndrome.
Kim CH; Kim HJ; Mitsuhashi M; Vaziri ND
Metabolism; 2007 Oct; 56(10):1377-82. PubMed ID: 17884448
[TBL] [Abstract][Full Text] [Related]
39. Blockage of the ERK signaling pathway abrogates the SCAP ligand-induced transcriptional activation of the LDL receptor gene in HepG2 cells.
Abidi P; Zhang F; Li C; Liu J
Int J Mol Med; 2005 Nov; 16(5):779-85. PubMed ID: 16211244
[TBL] [Abstract][Full Text] [Related]
40. Time- and dose-dependent effect of psyllium on serum lipids in mild-to-moderate hypercholesterolemia: a meta-analysis of controlled clinical trials.
Wei ZH; Wang H; Chen XY; Wang BS; Rong ZX; Wang BS; Su BH; Chen HZ
Eur J Clin Nutr; 2009 Jul; 63(7):821-7. PubMed ID: 18985059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
